Hybrigenics Gets €1.4M for Inecalcitol in Prostate Cancer
PARIS - Hybrigenics SA has been granted a refundable subsidy of €1.4 million (US$2 million) by France's state agency for promoting innovation and supporting small and medium-sized enterprises, OSEO, to finance the development of inecalcitol as a treatment for prostate cancer.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST